Global Celecoxib API Market Research Report 2026(Status and Outlook)
Celecoxib API refers to the active pharmaceutical ingredient (API) of the drug Celecoxib, which is a non-steroidal anti-inflammatory drug (NSAID) used to relieve pain, inflammation, and stiffness caused by conditions such as osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis. The Celecoxib API is the chemical compound responsible for the therapeutic effects of the drug. It is a selective cyclooxygenase-2 (COX-2) inhibitor, which means it works by blocking the production of prostaglandins, which are chemicals produced by the body in response to injury or inflammation. By reducing the production of prostaglandins, Celecoxib can help relieve pain, reduce inflammation, and improve joint mobility. The Celecoxib API is typically manufactured by pharmaceutical companies in accordance with strict quality control standards to ensure its purity, potency, and safety. It is then used to produce finished dosage forms of Celecoxib, such as tablets or capsules, which are prescribed by healthcare professionals to treat various inflammatory conditions.Global key players of celecoxib API include Pfizer, Jiangxi Synergy, ScinoPharm, Jiangsu Hengrui Medicine, Jiangsu Chiatai Qingjiang, etc. The top five players hold a share over 73%. Asia Pacific is the largest market, has a share about 43%, followed by North America and Europe, with share 28% and 25%, separately.
The global Celecoxib API market size was estimated at USD 64.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 4.90% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Celecoxib API market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Celecoxib API market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Celecoxib API market.
Global Celecoxib API Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Pfizer
Teva Pharmaceuticals
Viatris(Mylan)
ScinoPharm
Jiangxi Synergy
Jiangsu Hengrui Medicine
Jiangsu Chiatai Qingjiang
Hisun Pharmaceutical Nantong
Aurobindo Pharma
Punjab Chemicals
Market Segmentation (by Type)
Standard grade Celecoxib API
Micronized Celecoxib API
Market Segmentation (by Application)
Pharmaceutical
Laboratory
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Celecoxib API Market
Overview of the regional outlook of the Celecoxib API Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Celecoxib API Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Celecoxib API, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global Celecoxib API market size was estimated at USD 64.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 4.90% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Celecoxib API market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Celecoxib API market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Celecoxib API market.
Global Celecoxib API Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Pfizer
Teva Pharmaceuticals
Viatris(Mylan)
ScinoPharm
Jiangxi Synergy
Jiangsu Hengrui Medicine
Jiangsu Chiatai Qingjiang
Hisun Pharmaceutical Nantong
Aurobindo Pharma
Punjab Chemicals
Market Segmentation (by Type)
Standard grade Celecoxib API
Micronized Celecoxib API
Market Segmentation (by Application)
Pharmaceutical
Laboratory
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Celecoxib API Market
Overview of the regional outlook of the Celecoxib API Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Celecoxib API Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Celecoxib API, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Celecoxib API
1.2 Key Market Segments
1.2.1 Celecoxib API Segment by Type
1.2.2 Celecoxib API Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 CELECOXIB API MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Celecoxib API Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Celecoxib API Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 CELECOXIB API MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Celecoxib API Product Life Cycle
3.3 Global Celecoxib API Sales by Manufacturers (2020-2025)
3.4 Global Celecoxib API Revenue Market Share by Manufacturers (2020-2025)
3.5 Celecoxib API Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Celecoxib API Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Celecoxib API Market Competitive Situation and Trends
3.8.1 Celecoxib API Market Concentration Rate
3.8.2 Global 5 and 10 Largest Celecoxib API Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 CELECOXIB API INDUSTRY CHAIN ANALYSIS
4.1 Celecoxib API Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF CELECOXIB API MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Celecoxib API Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Celecoxib API Market
5.7 ESG Ratings of Leading Companies
6 CELECOXIB API MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Celecoxib API Sales Market Share by Type (2020-2025)
6.3 Global Celecoxib API Market Size by Type (2020-2025)
6.4 Global Celecoxib API Price by Type (2020-2025)
7 CELECOXIB API MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Celecoxib API Market Sales by Application (2020-2025)
7.3 Global Celecoxib API Market Size (M USD) by Application (2020-2025)
7.4 Global Celecoxib API Sales Growth Rate by Application (2020-2025)
8 CELECOXIB API MARKET SALES BY REGION
8.1 Global Celecoxib API Sales by Region
8.1.1 Global Celecoxib API Sales by Region
8.1.2 Global Celecoxib API Sales Market Share by Region
8.2 Global Celecoxib API Market Size by Region
8.2.1 Global Celecoxib API Market Size by Region
8.2.2 Global Celecoxib API Market Size by Region
8.3 North America
8.3.1 North America Celecoxib API Sales by Country
8.3.2 North America Celecoxib API Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Celecoxib API Sales by Country
8.4.2 Europe Celecoxib API Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Celecoxib API Sales by Region
8.5.2 Asia Pacific Celecoxib API Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Celecoxib API Sales by Country
8.6.2 South America Celecoxib API Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Celecoxib API Sales by Region
8.7.2 Middle East and Africa Celecoxib API Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 CELECOXIB API MARKET PRODUCTION BY REGION
9.1 Global Production of Celecoxib API by Region(2020-2025)
9.2 Global Celecoxib API Revenue Market Share by Region (2020-2025)
9.3 Global Celecoxib API Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Celecoxib API Production
9.4.1 North America Celecoxib API Production Growth Rate (2020-2025)
9.4.2 North America Celecoxib API Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Celecoxib API Production
9.5.1 Europe Celecoxib API Production Growth Rate (2020-2025)
9.5.2 Europe Celecoxib API Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Celecoxib API Production (2020-2025)
9.6.1 Japan Celecoxib API Production Growth Rate (2020-2025)
9.6.2 Japan Celecoxib API Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Celecoxib API Production (2020-2025)
9.7.1 China Celecoxib API Production Growth Rate (2020-2025)
9.7.2 China Celecoxib API Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Pfizer
10.1.1 Pfizer Basic Information
10.1.2 Pfizer Celecoxib API Product Overview
10.1.3 Pfizer Celecoxib API Product Market Performance
10.1.4 Pfizer Business Overview
10.1.5 Pfizer SWOT Analysis
10.1.6 Pfizer Recent Developments
10.2 Teva Pharmaceuticals
10.2.1 Teva Pharmaceuticals Basic Information
10.2.2 Teva Pharmaceuticals Celecoxib API Product Overview
10.2.3 Teva Pharmaceuticals Celecoxib API Product Market Performance
10.2.4 Teva Pharmaceuticals Business Overview
10.2.5 Teva Pharmaceuticals SWOT Analysis
10.2.6 Teva Pharmaceuticals Recent Developments
10.3 Viatris(Mylan)
10.3.1 Viatris(Mylan) Basic Information
10.3.2 Viatris(Mylan) Celecoxib API Product Overview
10.3.3 Viatris(Mylan) Celecoxib API Product Market Performance
10.3.4 Viatris(Mylan) Business Overview
10.3.5 Viatris(Mylan) SWOT Analysis
10.3.6 Viatris(Mylan) Recent Developments
10.4 ScinoPharm
10.4.1 ScinoPharm Basic Information
10.4.2 ScinoPharm Celecoxib API Product Overview
10.4.3 ScinoPharm Celecoxib API Product Market Performance
10.4.4 ScinoPharm Business Overview
10.4.5 ScinoPharm Recent Developments
10.5 Jiangxi Synergy
10.5.1 Jiangxi Synergy Basic Information
10.5.2 Jiangxi Synergy Celecoxib API Product Overview
10.5.3 Jiangxi Synergy Celecoxib API Product Market Performance
10.5.4 Jiangxi Synergy Business Overview
10.5.5 Jiangxi Synergy Recent Developments
10.6 Jiangsu Hengrui Medicine
10.6.1 Jiangsu Hengrui Medicine Basic Information
10.6.2 Jiangsu Hengrui Medicine Celecoxib API Product Overview
10.6.3 Jiangsu Hengrui Medicine Celecoxib API Product Market Performance
10.6.4 Jiangsu Hengrui Medicine Business Overview
10.6.5 Jiangsu Hengrui Medicine Recent Developments
10.7 Jiangsu Chiatai Qingjiang
10.7.1 Jiangsu Chiatai Qingjiang Basic Information
10.7.2 Jiangsu Chiatai Qingjiang Celecoxib API Product Overview
10.7.3 Jiangsu Chiatai Qingjiang Celecoxib API Product Market Performance
10.7.4 Jiangsu Chiatai Qingjiang Business Overview
10.7.5 Jiangsu Chiatai Qingjiang Recent Developments
10.8 Hisun Pharmaceutical Nantong
10.8.1 Hisun Pharmaceutical Nantong Basic Information
10.8.2 Hisun Pharmaceutical Nantong Celecoxib API Product Overview
10.8.3 Hisun Pharmaceutical Nantong Celecoxib API Product Market Performance
10.8.4 Hisun Pharmaceutical Nantong Business Overview
10.8.5 Hisun Pharmaceutical Nantong Recent Developments
10.9 Aurobindo Pharma
10.9.1 Aurobindo Pharma Basic Information
10.9.2 Aurobindo Pharma Celecoxib API Product Overview
10.9.3 Aurobindo Pharma Celecoxib API Product Market Performance
10.9.4 Aurobindo Pharma Business Overview
10.9.5 Aurobindo Pharma Recent Developments
10.10 Punjab Chemicals
10.10.1 Punjab Chemicals Basic Information
10.10.2 Punjab Chemicals Celecoxib API Product Overview
10.10.3 Punjab Chemicals Celecoxib API Product Market Performance
10.10.4 Punjab Chemicals Business Overview
10.10.5 Punjab Chemicals Recent Developments
11 CELECOXIB API MARKET FORECAST BY REGION
11.1 Global Celecoxib API Market Size Forecast
11.2 Global Celecoxib API Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Celecoxib API Market Size Forecast by Country
11.2.3 Asia Pacific Celecoxib API Market Size Forecast by Region
11.2.4 South America Celecoxib API Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Celecoxib API by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Celecoxib API Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Celecoxib API by Type (2026-2035)
12.1.2 Global Celecoxib API Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Celecoxib API by Type (2026-2035)
12.2 Global Celecoxib API Market Forecast by Application (2026-2035)
12.2.1 Global Celecoxib API Sales (K MT) Forecast by Application
12.2.2 Global Celecoxib API Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Celecoxib API
1.2 Key Market Segments
1.2.1 Celecoxib API Segment by Type
1.2.2 Celecoxib API Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 CELECOXIB API MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Celecoxib API Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Celecoxib API Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 CELECOXIB API MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Celecoxib API Product Life Cycle
3.3 Global Celecoxib API Sales by Manufacturers (2020-2025)
3.4 Global Celecoxib API Revenue Market Share by Manufacturers (2020-2025)
3.5 Celecoxib API Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Celecoxib API Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Celecoxib API Market Competitive Situation and Trends
3.8.1 Celecoxib API Market Concentration Rate
3.8.2 Global 5 and 10 Largest Celecoxib API Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 CELECOXIB API INDUSTRY CHAIN ANALYSIS
4.1 Celecoxib API Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF CELECOXIB API MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Celecoxib API Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Celecoxib API Market
5.7 ESG Ratings of Leading Companies
6 CELECOXIB API MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Celecoxib API Sales Market Share by Type (2020-2025)
6.3 Global Celecoxib API Market Size by Type (2020-2025)
6.4 Global Celecoxib API Price by Type (2020-2025)
7 CELECOXIB API MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Celecoxib API Market Sales by Application (2020-2025)
7.3 Global Celecoxib API Market Size (M USD) by Application (2020-2025)
7.4 Global Celecoxib API Sales Growth Rate by Application (2020-2025)
8 CELECOXIB API MARKET SALES BY REGION
8.1 Global Celecoxib API Sales by Region
8.1.1 Global Celecoxib API Sales by Region
8.1.2 Global Celecoxib API Sales Market Share by Region
8.2 Global Celecoxib API Market Size by Region
8.2.1 Global Celecoxib API Market Size by Region
8.2.2 Global Celecoxib API Market Size by Region
8.3 North America
8.3.1 North America Celecoxib API Sales by Country
8.3.2 North America Celecoxib API Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Celecoxib API Sales by Country
8.4.2 Europe Celecoxib API Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Celecoxib API Sales by Region
8.5.2 Asia Pacific Celecoxib API Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Celecoxib API Sales by Country
8.6.2 South America Celecoxib API Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Celecoxib API Sales by Region
8.7.2 Middle East and Africa Celecoxib API Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 CELECOXIB API MARKET PRODUCTION BY REGION
9.1 Global Production of Celecoxib API by Region(2020-2025)
9.2 Global Celecoxib API Revenue Market Share by Region (2020-2025)
9.3 Global Celecoxib API Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Celecoxib API Production
9.4.1 North America Celecoxib API Production Growth Rate (2020-2025)
9.4.2 North America Celecoxib API Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Celecoxib API Production
9.5.1 Europe Celecoxib API Production Growth Rate (2020-2025)
9.5.2 Europe Celecoxib API Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Celecoxib API Production (2020-2025)
9.6.1 Japan Celecoxib API Production Growth Rate (2020-2025)
9.6.2 Japan Celecoxib API Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Celecoxib API Production (2020-2025)
9.7.1 China Celecoxib API Production Growth Rate (2020-2025)
9.7.2 China Celecoxib API Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Pfizer
10.1.1 Pfizer Basic Information
10.1.2 Pfizer Celecoxib API Product Overview
10.1.3 Pfizer Celecoxib API Product Market Performance
10.1.4 Pfizer Business Overview
10.1.5 Pfizer SWOT Analysis
10.1.6 Pfizer Recent Developments
10.2 Teva Pharmaceuticals
10.2.1 Teva Pharmaceuticals Basic Information
10.2.2 Teva Pharmaceuticals Celecoxib API Product Overview
10.2.3 Teva Pharmaceuticals Celecoxib API Product Market Performance
10.2.4 Teva Pharmaceuticals Business Overview
10.2.5 Teva Pharmaceuticals SWOT Analysis
10.2.6 Teva Pharmaceuticals Recent Developments
10.3 Viatris(Mylan)
10.3.1 Viatris(Mylan) Basic Information
10.3.2 Viatris(Mylan) Celecoxib API Product Overview
10.3.3 Viatris(Mylan) Celecoxib API Product Market Performance
10.3.4 Viatris(Mylan) Business Overview
10.3.5 Viatris(Mylan) SWOT Analysis
10.3.6 Viatris(Mylan) Recent Developments
10.4 ScinoPharm
10.4.1 ScinoPharm Basic Information
10.4.2 ScinoPharm Celecoxib API Product Overview
10.4.3 ScinoPharm Celecoxib API Product Market Performance
10.4.4 ScinoPharm Business Overview
10.4.5 ScinoPharm Recent Developments
10.5 Jiangxi Synergy
10.5.1 Jiangxi Synergy Basic Information
10.5.2 Jiangxi Synergy Celecoxib API Product Overview
10.5.3 Jiangxi Synergy Celecoxib API Product Market Performance
10.5.4 Jiangxi Synergy Business Overview
10.5.5 Jiangxi Synergy Recent Developments
10.6 Jiangsu Hengrui Medicine
10.6.1 Jiangsu Hengrui Medicine Basic Information
10.6.2 Jiangsu Hengrui Medicine Celecoxib API Product Overview
10.6.3 Jiangsu Hengrui Medicine Celecoxib API Product Market Performance
10.6.4 Jiangsu Hengrui Medicine Business Overview
10.6.5 Jiangsu Hengrui Medicine Recent Developments
10.7 Jiangsu Chiatai Qingjiang
10.7.1 Jiangsu Chiatai Qingjiang Basic Information
10.7.2 Jiangsu Chiatai Qingjiang Celecoxib API Product Overview
10.7.3 Jiangsu Chiatai Qingjiang Celecoxib API Product Market Performance
10.7.4 Jiangsu Chiatai Qingjiang Business Overview
10.7.5 Jiangsu Chiatai Qingjiang Recent Developments
10.8 Hisun Pharmaceutical Nantong
10.8.1 Hisun Pharmaceutical Nantong Basic Information
10.8.2 Hisun Pharmaceutical Nantong Celecoxib API Product Overview
10.8.3 Hisun Pharmaceutical Nantong Celecoxib API Product Market Performance
10.8.4 Hisun Pharmaceutical Nantong Business Overview
10.8.5 Hisun Pharmaceutical Nantong Recent Developments
10.9 Aurobindo Pharma
10.9.1 Aurobindo Pharma Basic Information
10.9.2 Aurobindo Pharma Celecoxib API Product Overview
10.9.3 Aurobindo Pharma Celecoxib API Product Market Performance
10.9.4 Aurobindo Pharma Business Overview
10.9.5 Aurobindo Pharma Recent Developments
10.10 Punjab Chemicals
10.10.1 Punjab Chemicals Basic Information
10.10.2 Punjab Chemicals Celecoxib API Product Overview
10.10.3 Punjab Chemicals Celecoxib API Product Market Performance
10.10.4 Punjab Chemicals Business Overview
10.10.5 Punjab Chemicals Recent Developments
11 CELECOXIB API MARKET FORECAST BY REGION
11.1 Global Celecoxib API Market Size Forecast
11.2 Global Celecoxib API Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Celecoxib API Market Size Forecast by Country
11.2.3 Asia Pacific Celecoxib API Market Size Forecast by Region
11.2.4 South America Celecoxib API Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Celecoxib API by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Celecoxib API Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Celecoxib API by Type (2026-2035)
12.1.2 Global Celecoxib API Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Celecoxib API by Type (2026-2035)
12.2 Global Celecoxib API Market Forecast by Application (2026-2035)
12.2.1 Global Celecoxib API Sales (K MT) Forecast by Application
12.2.2 Global Celecoxib API Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Celecoxib API Market Size by Type (M USD)
Table 4. Global Celecoxib API Market Size by Application
Table 5. Celecoxib API Market Size Comparison by Region (M USD)
Table 6. Global Celecoxib API Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Celecoxib API Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Celecoxib API Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Celecoxib API Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Celecoxib API as of 2025)
Table 11. Global Market Celecoxib API Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Celecoxib API Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Celecoxib API Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Celecoxib API Sales by Type (K MT)
Table 27. Global Celecoxib API Market Size by Type (M USD)
Table 28. Global Celecoxib API Sales (K MT) by Type (2020-2025)
Table 29. Global Celecoxib API Sales Market Share by Type (2020-2025)
Table 30. Global Celecoxib API Market Size (M USD) by Type (2020-2025)
Table 31. Global Celecoxib API Market Share by Type (2020-2025)
Table 32. Global Celecoxib API Price (USD/KG) by Type (2020-2025)
Table 33. Global Celecoxib API Sales (K MT) by Application
Table 34. Global Celecoxib API Market Size by Application
Table 35. Global Celecoxib API Sales by Application (2020-2025) & (K MT)
Table 36. Global Celecoxib API Sales Market Share by Application (2020-2025)
Table 37. Global Celecoxib API Market Size by Application (2020-2025) & (M USD)
Table 38. Global Celecoxib API Market Share by Application (2020-2025)
Table 39. Global Celecoxib API Sales Growth Rate by Application (2020-2025)
Table 40. Global Celecoxib API Sales by Region (2020-2025) & (K MT)
Table 41. Global Celecoxib API Sales Market Share by Region (2020-2025)
Table 42. Global Celecoxib API Market Size by Region (2020-2025) & (M USD)
Table 43. Global Celecoxib API Market Size by Region (2020-2025)
Table 44. North America Celecoxib API Sales by Country (2020-2025) & (K MT)
Table 45. North America Celecoxib API Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Celecoxib API Sales by Country (2020-2025) & (K MT)
Table 47. Europe Celecoxib API Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Celecoxib API Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Celecoxib API Market Size by Region (2020-2025) & (M USD)
Table 50. South America Celecoxib API Sales by Country (2020-2025) & (K MT)
Table 51. South America Celecoxib API Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Celecoxib API Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Celecoxib API Market Size by Region (2020-2025) & (M USD)
Table 54. Global Celecoxib API Production (K MT) by Region(2020-2025)
Table 55. Global Celecoxib API Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Celecoxib API Revenue Market Share by Region (2020-2025)
Table 57. Global Celecoxib API Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Celecoxib API Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Celecoxib API Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Celecoxib API Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Celecoxib API Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Pfizer Basic Information
Table 63. Pfizer Celecoxib API Product Overview
Table 64. Pfizer Celecoxib API Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Pfizer Business Overview
Table 66. Pfizer SWOT Analysis
Table 67. Pfizer Recent Developments
Table 68. Teva Pharmaceuticals Basic Information
Table 69. Teva Pharmaceuticals Celecoxib API Product Overview
Table 70. Teva Pharmaceuticals Celecoxib API Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. Teva Pharmaceuticals Business Overview
Table 72. Teva Pharmaceuticals SWOT Analysis
Table 73. Teva Pharmaceuticals Recent Developments
Table 74. Viatris(Mylan) Basic Information
Table 75. Viatris(Mylan) Celecoxib API Product Overview
Table 76. Viatris(Mylan) Celecoxib API Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Viatris(Mylan) Business Overview
Table 78. Viatris(Mylan) SWOT Analysis
Table 79. Viatris(Mylan) Recent Developments
Table 80. ScinoPharm Basic Information
Table 81. ScinoPharm Celecoxib API Product Overview
Table 82. ScinoPharm Celecoxib API Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. ScinoPharm Business Overview
Table 84. ScinoPharm Recent Developments
Table 85. Jiangxi Synergy Basic Information
Table 86. Jiangxi Synergy Celecoxib API Product Overview
Table 87. Jiangxi Synergy Celecoxib API Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. Jiangxi Synergy Business Overview
Table 89. Jiangxi Synergy Recent Developments
Table 90. Jiangsu Hengrui Medicine Basic Information
Table 91. Jiangsu Hengrui Medicine Celecoxib API Product Overview
Table 92. Jiangsu Hengrui Medicine Celecoxib API Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. Jiangsu Hengrui Medicine Business Overview
Table 94. Jiangsu Hengrui Medicine Recent Developments
Table 95. Jiangsu Chiatai Qingjiang Basic Information
Table 96. Jiangsu Chiatai Qingjiang Celecoxib API Product Overview
Table 97. Jiangsu Chiatai Qingjiang Celecoxib API Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. Jiangsu Chiatai Qingjiang Business Overview
Table 99. Jiangsu Chiatai Qingjiang Recent Developments
Table 100. Hisun Pharmaceutical Nantong Basic Information
Table 101. Hisun Pharmaceutical Nantong Celecoxib API Product Overview
Table 102. Hisun Pharmaceutical Nantong Celecoxib API Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. Hisun Pharmaceutical Nantong Business Overview
Table 104. Hisun Pharmaceutical Nantong Recent Developments
Table 105. Aurobindo Pharma Basic Information
Table 106. Aurobindo Pharma Celecoxib API Product Overview
Table 107. Aurobindo Pharma Celecoxib API Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. Aurobindo Pharma Business Overview
Table 109. Aurobindo Pharma Recent Developments
Table 110. Punjab Chemicals Basic Information
Table 111. Punjab Chemicals Celecoxib API Product Overview
Table 112. Punjab Chemicals Celecoxib API Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 113. Punjab Chemicals Business Overview
Table 114. Punjab Chemicals Recent Developments
Table 115. Global Celecoxib API Sales Forecast by Region (2026-2035) & (K MT)
Table 116. Global Celecoxib API Market Size Forecast by Region (2026-2035) & (M USD)
Table 117. North America Celecoxib API Sales Forecast by Country (2026-2035) & (K MT)
Table 118. North America Celecoxib API Market Size Forecast by Country (2026-2035) & (M USD)
Table 119. Europe Celecoxib API Sales Forecast by Country (2026-2035) & (K MT)
Table 120. Europe Celecoxib API Market Size Forecast by Country (2026-2035) & (M USD)
Table 121. Asia Pacific Celecoxib API Sales Forecast by Region (2026-2035) & (K MT)
Table 122. Asia Pacific Celecoxib API Market Size Forecast by Region (2026-2035) & (M USD)
Table 123. South America Celecoxib API Sales Forecast by Country (2026-2035) & (K MT)
Table 124. South America Celecoxib API Market Size Forecast by Country (2026-2035) & (M USD)
Table 125. Middle East and Africa Celecoxib API Sales Forecast by Country (2026-2035) & (Units)
Table 126. Middle East and Africa Celecoxib API Market Size Forecast by Country (2026-2035) & (M USD)
Table 127. Global Celecoxib API Sales Forecast by Type (2026-2035) & (K MT)
Table 128. Global Celecoxib API Market Size Forecast by Type (2026-2035) & (M USD)
Table 129. Global Celecoxib API Price Forecast by Type (2026-2035) & (USD/KG)
Table 130. Global Celecoxib API Sales (K MT) Forecast by Application (2026-2035)
Table 131. Global Celecoxib API Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Celecoxib API Market Size by Type (M USD)
Table 4. Global Celecoxib API Market Size by Application
Table 5. Celecoxib API Market Size Comparison by Region (M USD)
Table 6. Global Celecoxib API Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Celecoxib API Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Celecoxib API Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Celecoxib API Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Celecoxib API as of 2025)
Table 11. Global Market Celecoxib API Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Celecoxib API Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Celecoxib API Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Celecoxib API Sales by Type (K MT)
Table 27. Global Celecoxib API Market Size by Type (M USD)
Table 28. Global Celecoxib API Sales (K MT) by Type (2020-2025)
Table 29. Global Celecoxib API Sales Market Share by Type (2020-2025)
Table 30. Global Celecoxib API Market Size (M USD) by Type (2020-2025)
Table 31. Global Celecoxib API Market Share by Type (2020-2025)
Table 32. Global Celecoxib API Price (USD/KG) by Type (2020-2025)
Table 33. Global Celecoxib API Sales (K MT) by Application
Table 34. Global Celecoxib API Market Size by Application
Table 35. Global Celecoxib API Sales by Application (2020-2025) & (K MT)
Table 36. Global Celecoxib API Sales Market Share by Application (2020-2025)
Table 37. Global Celecoxib API Market Size by Application (2020-2025) & (M USD)
Table 38. Global Celecoxib API Market Share by Application (2020-2025)
Table 39. Global Celecoxib API Sales Growth Rate by Application (2020-2025)
Table 40. Global Celecoxib API Sales by Region (2020-2025) & (K MT)
Table 41. Global Celecoxib API Sales Market Share by Region (2020-2025)
Table 42. Global Celecoxib API Market Size by Region (2020-2025) & (M USD)
Table 43. Global Celecoxib API Market Size by Region (2020-2025)
Table 44. North America Celecoxib API Sales by Country (2020-2025) & (K MT)
Table 45. North America Celecoxib API Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Celecoxib API Sales by Country (2020-2025) & (K MT)
Table 47. Europe Celecoxib API Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Celecoxib API Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Celecoxib API Market Size by Region (2020-2025) & (M USD)
Table 50. South America Celecoxib API Sales by Country (2020-2025) & (K MT)
Table 51. South America Celecoxib API Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Celecoxib API Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Celecoxib API Market Size by Region (2020-2025) & (M USD)
Table 54. Global Celecoxib API Production (K MT) by Region(2020-2025)
Table 55. Global Celecoxib API Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Celecoxib API Revenue Market Share by Region (2020-2025)
Table 57. Global Celecoxib API Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Celecoxib API Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Celecoxib API Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Celecoxib API Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Celecoxib API Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Pfizer Basic Information
Table 63. Pfizer Celecoxib API Product Overview
Table 64. Pfizer Celecoxib API Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Pfizer Business Overview
Table 66. Pfizer SWOT Analysis
Table 67. Pfizer Recent Developments
Table 68. Teva Pharmaceuticals Basic Information
Table 69. Teva Pharmaceuticals Celecoxib API Product Overview
Table 70. Teva Pharmaceuticals Celecoxib API Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. Teva Pharmaceuticals Business Overview
Table 72. Teva Pharmaceuticals SWOT Analysis
Table 73. Teva Pharmaceuticals Recent Developments
Table 74. Viatris(Mylan) Basic Information
Table 75. Viatris(Mylan) Celecoxib API Product Overview
Table 76. Viatris(Mylan) Celecoxib API Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Viatris(Mylan) Business Overview
Table 78. Viatris(Mylan) SWOT Analysis
Table 79. Viatris(Mylan) Recent Developments
Table 80. ScinoPharm Basic Information
Table 81. ScinoPharm Celecoxib API Product Overview
Table 82. ScinoPharm Celecoxib API Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. ScinoPharm Business Overview
Table 84. ScinoPharm Recent Developments
Table 85. Jiangxi Synergy Basic Information
Table 86. Jiangxi Synergy Celecoxib API Product Overview
Table 87. Jiangxi Synergy Celecoxib API Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. Jiangxi Synergy Business Overview
Table 89. Jiangxi Synergy Recent Developments
Table 90. Jiangsu Hengrui Medicine Basic Information
Table 91. Jiangsu Hengrui Medicine Celecoxib API Product Overview
Table 92. Jiangsu Hengrui Medicine Celecoxib API Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. Jiangsu Hengrui Medicine Business Overview
Table 94. Jiangsu Hengrui Medicine Recent Developments
Table 95. Jiangsu Chiatai Qingjiang Basic Information
Table 96. Jiangsu Chiatai Qingjiang Celecoxib API Product Overview
Table 97. Jiangsu Chiatai Qingjiang Celecoxib API Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. Jiangsu Chiatai Qingjiang Business Overview
Table 99. Jiangsu Chiatai Qingjiang Recent Developments
Table 100. Hisun Pharmaceutical Nantong Basic Information
Table 101. Hisun Pharmaceutical Nantong Celecoxib API Product Overview
Table 102. Hisun Pharmaceutical Nantong Celecoxib API Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. Hisun Pharmaceutical Nantong Business Overview
Table 104. Hisun Pharmaceutical Nantong Recent Developments
Table 105. Aurobindo Pharma Basic Information
Table 106. Aurobindo Pharma Celecoxib API Product Overview
Table 107. Aurobindo Pharma Celecoxib API Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. Aurobindo Pharma Business Overview
Table 109. Aurobindo Pharma Recent Developments
Table 110. Punjab Chemicals Basic Information
Table 111. Punjab Chemicals Celecoxib API Product Overview
Table 112. Punjab Chemicals Celecoxib API Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 113. Punjab Chemicals Business Overview
Table 114. Punjab Chemicals Recent Developments
Table 115. Global Celecoxib API Sales Forecast by Region (2026-2035) & (K MT)
Table 116. Global Celecoxib API Market Size Forecast by Region (2026-2035) & (M USD)
Table 117. North America Celecoxib API Sales Forecast by Country (2026-2035) & (K MT)
Table 118. North America Celecoxib API Market Size Forecast by Country (2026-2035) & (M USD)
Table 119. Europe Celecoxib API Sales Forecast by Country (2026-2035) & (K MT)
Table 120. Europe Celecoxib API Market Size Forecast by Country (2026-2035) & (M USD)
Table 121. Asia Pacific Celecoxib API Sales Forecast by Region (2026-2035) & (K MT)
Table 122. Asia Pacific Celecoxib API Market Size Forecast by Region (2026-2035) & (M USD)
Table 123. South America Celecoxib API Sales Forecast by Country (2026-2035) & (K MT)
Table 124. South America Celecoxib API Market Size Forecast by Country (2026-2035) & (M USD)
Table 125. Middle East and Africa Celecoxib API Sales Forecast by Country (2026-2035) & (Units)
Table 126. Middle East and Africa Celecoxib API Market Size Forecast by Country (2026-2035) & (M USD)
Table 127. Global Celecoxib API Sales Forecast by Type (2026-2035) & (K MT)
Table 128. Global Celecoxib API Market Size Forecast by Type (2026-2035) & (M USD)
Table 129. Global Celecoxib API Price Forecast by Type (2026-2035) & (USD/KG)
Table 130. Global Celecoxib API Sales (K MT) Forecast by Application (2026-2035)
Table 131. Global Celecoxib API Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Celecoxib API
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Celecoxib API Market Size (M USD), 2025-2035
Figure 5. Global Celecoxib API Market Size (M USD) (2020-2035)
Figure 6. Global Celecoxib API Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Celecoxib API Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Celecoxib API Product Life Cycle
Figure 13. Celecoxib API Sales Share by Manufacturers in 2025
Figure 14. Global Celecoxib API Revenue Share by Manufacturers in 2025
Figure 15. Celecoxib API Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Celecoxib API Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Celecoxib API Revenue in 2025
Figure 18. Industry Chain Map of Celecoxib API
Figure 19. Global Celecoxib API Market PEST Analysis
Figure 20. Global Celecoxib API Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Celecoxib API Market Share by Type
Figure 27. Sales Market Share of Celecoxib API by Type (2020-2025)
Figure 28. Sales Market Share of Celecoxib API by Type in 2025
Figure 29. Market Share of Celecoxib API by Type (2020-2025)
Figure 30. Market Share of Celecoxib API by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Celecoxib API Market Share by Application
Figure 33. Global Celecoxib API Sales Market Share by Application (2020-2025)
Figure 34. Global Celecoxib API Sales Market Share by Application in 2025
Figure 35. Global Celecoxib API Market Share by Application (2020-2025)
Figure 36. Global Celecoxib API Market Share by Application in 2025
Figure 37. Global Celecoxib API Sales Growth Rate by Application (2020-2025)
Figure 38. Global Celecoxib API Sales Market Share by Region (2020-2025)
Figure 39. Global Celecoxib API Market Size by Region (2020-2025)
Figure 40. North America Celecoxib API Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Celecoxib API Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Celecoxib API Sales Market Share by Country in 2024
Figure 43. North America Celecoxib API Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Celecoxib API Market Size by Country in 2024
Figure 45. U.S. Celecoxib API Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Celecoxib API Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Celecoxib API Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Celecoxib API Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Celecoxib API Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Celecoxib API Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Celecoxib API Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Celecoxib API Sales Market Share by Country in 2024
Figure 53. Europe Celecoxib API Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Celecoxib API Market Size by Country in 2024
Figure 55. Germany Celecoxib API Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Celecoxib API Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Celecoxib API Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Celecoxib API Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Celecoxib API Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Celecoxib API Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Celecoxib API Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Celecoxib API Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Celecoxib API Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Celecoxib API Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Celecoxib API Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Celecoxib API Sales Market Share by Region in 2024
Figure 67. Asia Pacific Celecoxib API Market Size by Region in 2024
Figure 68. China Celecoxib API Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Celecoxib API Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Celecoxib API Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Celecoxib API Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Celecoxib API Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Celecoxib API Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Celecoxib API Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Celecoxib API Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Celecoxib API Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Celecoxib API Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Celecoxib API Sales and Growth Rate (K MT)
Figure 79. South America Celecoxib API Sales Market Share by Country in 2024
Figure 80. South America Celecoxib API Market Size and Growth Rate (M USD)
Figure 81. South America Celecoxib API Market Size by Country in 2024
Figure 82. Brazil Celecoxib API Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Celecoxib API Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Celecoxib API Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Celecoxib API Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Celecoxib API Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Celecoxib API Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Celecoxib API Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Celecoxib API Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Celecoxib API Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Celecoxib API Market Size by Region in 2024
Figure 92. Saudi Arabia Celecoxib API Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Celecoxib API Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Celecoxib API Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Celecoxib API Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Celecoxib API Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Celecoxib API Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Celecoxib API Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Celecoxib API Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Celecoxib API Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Celecoxib API Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Celecoxib API Production Market Share by Region (2020-2025)
Figure 103. North America Celecoxib API Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Celecoxib API Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Celecoxib API Production (K MT) Growth Rate (2020-2025)
Figure 106. China Celecoxib API Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Celecoxib API Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Celecoxib API Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Celecoxib API Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Celecoxib API Market Share Forecast by Type (2026-2035)
Figure 111. Global Celecoxib API Sales Forecast by Application (2026-2035)
Figure 112. Global Celecoxib API Market Share Forecast by Application (2026-2035)
Figure 1. Product Picture of Celecoxib API
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Celecoxib API Market Size (M USD), 2025-2035
Figure 5. Global Celecoxib API Market Size (M USD) (2020-2035)
Figure 6. Global Celecoxib API Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Celecoxib API Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Celecoxib API Product Life Cycle
Figure 13. Celecoxib API Sales Share by Manufacturers in 2025
Figure 14. Global Celecoxib API Revenue Share by Manufacturers in 2025
Figure 15. Celecoxib API Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Celecoxib API Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Celecoxib API Revenue in 2025
Figure 18. Industry Chain Map of Celecoxib API
Figure 19. Global Celecoxib API Market PEST Analysis
Figure 20. Global Celecoxib API Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Celecoxib API Market Share by Type
Figure 27. Sales Market Share of Celecoxib API by Type (2020-2025)
Figure 28. Sales Market Share of Celecoxib API by Type in 2025
Figure 29. Market Share of Celecoxib API by Type (2020-2025)
Figure 30. Market Share of Celecoxib API by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Celecoxib API Market Share by Application
Figure 33. Global Celecoxib API Sales Market Share by Application (2020-2025)
Figure 34. Global Celecoxib API Sales Market Share by Application in 2025
Figure 35. Global Celecoxib API Market Share by Application (2020-2025)
Figure 36. Global Celecoxib API Market Share by Application in 2025
Figure 37. Global Celecoxib API Sales Growth Rate by Application (2020-2025)
Figure 38. Global Celecoxib API Sales Market Share by Region (2020-2025)
Figure 39. Global Celecoxib API Market Size by Region (2020-2025)
Figure 40. North America Celecoxib API Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Celecoxib API Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Celecoxib API Sales Market Share by Country in 2024
Figure 43. North America Celecoxib API Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Celecoxib API Market Size by Country in 2024
Figure 45. U.S. Celecoxib API Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Celecoxib API Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Celecoxib API Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Celecoxib API Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Celecoxib API Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Celecoxib API Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Celecoxib API Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Celecoxib API Sales Market Share by Country in 2024
Figure 53. Europe Celecoxib API Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Celecoxib API Market Size by Country in 2024
Figure 55. Germany Celecoxib API Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Celecoxib API Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Celecoxib API Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Celecoxib API Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Celecoxib API Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Celecoxib API Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Celecoxib API Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Celecoxib API Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Celecoxib API Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Celecoxib API Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Celecoxib API Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Celecoxib API Sales Market Share by Region in 2024
Figure 67. Asia Pacific Celecoxib API Market Size by Region in 2024
Figure 68. China Celecoxib API Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Celecoxib API Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Celecoxib API Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Celecoxib API Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Celecoxib API Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Celecoxib API Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Celecoxib API Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Celecoxib API Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Celecoxib API Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Celecoxib API Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Celecoxib API Sales and Growth Rate (K MT)
Figure 79. South America Celecoxib API Sales Market Share by Country in 2024
Figure 80. South America Celecoxib API Market Size and Growth Rate (M USD)
Figure 81. South America Celecoxib API Market Size by Country in 2024
Figure 82. Brazil Celecoxib API Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Celecoxib API Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Celecoxib API Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Celecoxib API Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Celecoxib API Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Celecoxib API Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Celecoxib API Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Celecoxib API Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Celecoxib API Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Celecoxib API Market Size by Region in 2024
Figure 92. Saudi Arabia Celecoxib API Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Celecoxib API Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Celecoxib API Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Celecoxib API Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Celecoxib API Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Celecoxib API Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Celecoxib API Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Celecoxib API Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Celecoxib API Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Celecoxib API Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Celecoxib API Production Market Share by Region (2020-2025)
Figure 103. North America Celecoxib API Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Celecoxib API Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Celecoxib API Production (K MT) Growth Rate (2020-2025)
Figure 106. China Celecoxib API Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Celecoxib API Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Celecoxib API Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Celecoxib API Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Celecoxib API Market Share Forecast by Type (2026-2035)
Figure 111. Global Celecoxib API Sales Forecast by Application (2026-2035)
Figure 112. Global Celecoxib API Market Share Forecast by Application (2026-2035)
